| Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
| 8 mg | 8 (8) | As recommended. | PO | For patients receiving emetogenic chemotherapy or radiotherapy: This dose should be administered 1-2 hours before treatment, followed by 8 mg orally twelve hourly. |
| 16 mg | 16 (16) | As recommended. | PO | For the prevention of post-operative nausea and vomiting: This dose should be given one hour prior to induction of anaesthesia. |
| 25 to 75 mg | 50 (50) | As recommended. | PO | When given as co-danthramer with poloxamer. |
| 50 to 150 mg | 100 (100) | As recommended. | PO | When given as co-danthrusate with dowsate sodium. |
Paedriatic Dosage (20kg)
|
| 25 to 12.5 mg | 19 (18.75) | As recommended. | P/O | Age 12 or above. |
Neonatal Dosage (3kg)
|
| No data regarding the neonatal dosage details of is available. |